Your session is about to expire
← Back to Search
Statins for High Cholesterol in Children
Study Summary
This trial looks at how well statins work in children with different levels of liver fat.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I cannot swallow pills.I am between 8 and 21 years old.I have the SLCO1B1 c.521TT genotype.I have had diarrhea in the past day.I have heart defects from birth or acquired that haven't been fixed or still cause issues after repair.I am taking statin medication and cannot stop it for 4 weeks before and during the study.I can safely undergo an MRI without issues like claustrophobia or having a pacemaker.I am not taking medication that affects statins.I have a condition that could affect how my body handles the drug rosuvastatin.
- Group 1: Baseline Mevalonate and MRI Imaging
- Group 2: Mevalonate Change After Rosuvastatin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What does Rosuvastatin 10mg typically target for treatment?
"A common treatment for hypertriglyceridemias is Rosuvastatin 10mg. This form of medication is also employed to address cardiovascular diseases, events, and surgeries."
What are the eligibility criteria for participants in this trial?
"For this medical trial, 50 individuals aged 8 to 21 with cholesterol are needed. The key requirements for participation include the SLCO1B1 c.521TT genotype, a minimum of eight hours of fasting, and providing informed permission-assent (if under 18) or consent (if over 18)."
What is the current participant count of this clinical trial?
"Affirmative, according to the data available on clinicaltrials.gov this study is actively seeking out potential participants. This medical trial was inaugurated on April 1st 2021 and last modified July 1st 2022; it requires 50 individuals from a single site."
Is enrollment still available for this experimental trial?
"Affirmative. Clinicaltrials.gov records demonstrate that this trial, which was first launched on April 1st 2021, is actively recruiting participants. It hopes to accept 50 patients from one medical center."
Is this clinical research open to geriatric participants?
"This experiment is open to participants aged 8 and above, up until 21 years old."
Has the FDA sanctioned Rosuvastatin 10mg for medicinal use?
"Rosuvastatin 10mg has only been minimally studied, so it was assigned a safety rating of 1 on the scale from our team at Power."
Share this study with friends
Copy Link
Messenger